l objective: the aim of the study was to compare the efficacy of a microorganism-binding (mB) dressing with a silver-containing hydrofiber (sch) dressing in controlling the bacterial loads of heavily colonised or locally infected chronic venous leg ulcers, before surgical management with homologous skin grafts. l Method: a randomised comparative single centre study recruited patients presenting with hard-toheal critically colonised or locally infected leg ulcers, who could be treated with skin grafting. inclusion criteria included; ulcers of vascular aetiology, over 18 years old, a wound duration ≥6 months and ankle brachial index (aBpi) >0.6. patients were randomly assigned to treatment with sch dressings (aquacel ag) or mB dressing (cutimed sorbact). dressings were changed daily over a four-day observation period, after which they were taken for a skin grafting procedure. swab samples from ulcer beds were taken in order to quantify the bacterial load at inclusion (d0) and at the end of the observation period day 4 (d4). no antibiotics were administered before or during the evaluation period. l results: Both groups (n=20 sch, n=20 mB) were similar in gender, age, pathophysiology (both had 15 patients with venous leg ulcers and 5 with arterial leg ulcers), ulcer surface, ulcer duration, treatmentrelated pain and initial bacterial load. analysing bacterial load variation showed a significant reduction of bacterial burden at d4 in both groups. in the sch group, we found an average bacterial load reduction of 41.6%, with an average reduction of 73.1% in the mB group (p< 0.00001). no serious adverse events were reported. l conclusion: our evaluation confirmed that mB and sch dressings are effective in reducing the bacterial burden in critically colonised or locally infected chronic leg ulcers, without inducing adverse events, with mB dressings significantly more effective. l declaration of interest: there were no external sources of funding for this study. the authors have no conflicts of interest to declare.
S kin grafting failure due to infection was proposed in 1951 by Jackson.1 In 1967 Krizek et al. published data showing that on average 94% of grafts survived when ≤105CFU/g were present in the tissue biopsies, whereas 19% survived when count exceeded 105CFU/g.2 Another study3 demonstrated the presence of Pseudomona aeruginosa and Staphylococcus aureus results in a significant probability of the skin graft failing to take. These finding were supported by Hogsberg et al.,4 who concluded that a successful skin graft 'take' is less likely to occur with wounds containing more than 105 viable bacteria per gram of tissue.
Bacteria can secrete a large number of enzymes such as hyaluronidase, fibrinolysins, and proteases. In the case of skin grafting, these may damage the growth of capillaries through the fibrin layer between the granulation tissue and the graft.
Critical colonisation is used to describe the level of bacteria that inhibits wound healing but does not display classical signs of infections.5 The term, which has been part of the wound care vocabulary for a long time, is frequently challenged6 but not yet disproved. Synonyms for critical colonisation include: silent infection, covert infection, occult infection, refractory wound, subclinical infection, indolent wound, stunned wound, subacute infection and recalcitrant wound.5 This means that clinical criteria are required to diagnose concealed infection.
Robson et al.7 defined infection as a level of >105 microorganisms/g of tissue, and using quantitative bacteriology, they found that wounds undergoing delayed closure with <10 CFU/g healed successfully, while those with >105CFU/g did not.
For ulcers with high bacterial loads, the correct choice of a dressing to reduce bioburden is important. Adequate delivery of bactericidal agents to an infected ulcer can be very difficult; the dressing must be able to effectively decrease the microorganism population (planktonic and biofilms), with a broad spectrum of action. The dressing must not be toxic or induce resistance. It is widely accepted that topical antibiotics should be avoided owing to the risk of increasing bacterial resistance and contact dermatitis.8
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